Prostate Cancer International is
for 2011 by Great NonProfits
The RTOG 94-08 clinical trial was designed to test the idea that just 4 months of hormone therapy, administered before and during radiation therapy, would improved the overall survival of patients diagnosed with clinical stage T1b-T2b prostate cancer and a PSA level equal to or lower than 20 ng/ml.
Filed under: Management, Treatment | Tagged: external beam radiation therapy, hormone therapy, localized disease, RTOG 94-08, survival | 1 Comment »
There are few good data on the occurrence of chronic fatigue after first-line treatment of localized prostate cancer.
Filed under: Living with Prostate Cancer, Management | Tagged: chronic, EBRT, external beam radiation therapy, fatigue, radical prostatctomy, RP, Treatment | Leave a Comment »
A newly published report suggests that sexual function does indeed decline after external beam radiation therapy (EBRT) for prostate cancer — but only over the first 2 years post-treatment.
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: EBRT, ED, erectile dysfucntion, external beam radiation therapy, sexual function | 2 Comments »
A paper in press in the Journal of Urology has suggested that, for patients with intermediate-risk prostate cancer who elect treatment with a combination of standard (low dose) brachytherapy and external beam radiation therapy (EBRT), the addition of hormone therapy adds little in terms of clinical benefit.
Filed under: Management, Treatment | Tagged: ADT, androgen deprivation therapy, brachytherapy, combination radiotherapy, EBRT, external beam radiation therapy | Leave a Comment »
Earlier this year we reported the initial results of a truly randomized Canadian trial of cryotherapy vs. external beam radiation therapy (EBRT) for the treatment of localized prostate cancer. The same group of authors have now reported follow-up data on quality of life.
Filed under: Management, Treatment | Tagged: cryoablation, cryotherapy, EBRT, external beam radiation therapy, randomized, trial | 2 Comments »
In today’s news reports you will find items on: Obesity and PSA levels Outcomes after external beam radiation therapy Mitoxantrone + predisone after taxotere failure
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: EBRT, external beam radiation therapy, mitoxantrone, obesity, outcome, prednisone, PSA level | Leave a Comment »
Todays news reports adddress: Surgeon and hospital volume and outcomes to radical prostatectomy Adverse events associated with the use of hypofractionated, dose-escalated, IMRT Quality of sexual function after external beam radiation therapy Percentage of positive biopsy cores and response to first-line hormone therapy
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment, Uncategorized | Tagged: biopsy, core, EBRT, external beam radiation therapy, hormone therapy, hospital, hypofractionated, IMRT, radical prostatectomy, sexual function, surgeon, volume | Leave a Comment »
The most common method for salvage therapy in men with recurrent, localized prostate cancer after first-line external beam radiation therapy (EBRT) is surgery. However, a newly published study reports one group’s experience with salvage permanent perineal radioactive-seed implantation (SPPI) as a possible therapeutic option for recurrent prostate adenocarcinoma after EBRT.
Filed under: Management, Treatment | Tagged: external beam radiation therapy, salvage brachytherapy | Leave a Comment »
Search for new and
ongoing trials on the
CTAG PCa web site